STUDIES OF RETROVIRAL PROTEIN-NUCLEIC ACID INTERACTIONS NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


STUDIES OF RETROVIRAL PROTEIN-NUCLEIC ACID INTERACTIONS

Diss Abstr Int [B]; 52(2):802 1991. Unique Identifier : AIDSLINE ICDB/92677992
Delahunty MD; Univ. of Maryland, Baltimore County


Abstract: The substrate interactions of two retroviral proteins were studied: the nucleocapsid (NC) protein and reverse transcriptase (RT). Retroviral NC proteins bind to retroviral RNA and contain one or two CysHis motifs which may be analogous to the CysHis motif of zinc fingers such as those found in the transcriptional activator TFIIIA. The gene for the full length NC protein from Moloney murine leukemia virus was cloned into an E coli expression vector in order to obtain sufficient quantities of protein to study the role of the CysHis motif in the binding of NC to nucleic acid. The resulting clone was shown by Northern blot analysis to be transcribed, but did not express NC protein in detectable levels. Nucleic acid binding studies were then pursued using a synthetic peptide that consists of the first CysHis motif of HIV-1 NC protein. The fluorescent polynucleotide, polyriboethenoadenylic acid (poly[eA]), was utilized to monitor peptide binding to nucleic acid. The apopeptide binds to poly(eA) with a larger site size and with less affinity at 1 mM sodium phosphate than the zinc-bound peptide does. The affinity is due to 1-2 electrostatic interactions as well as a nonelectrostatic contribution of about - 6 kcal/mol. The peptide binds to both single-stranded and double-stranded calf thymus DNA. Reverse transcriptase is the RNA-dependent DNA polymerase of the retrovirus, which plays an essential role in viral replication. An assay for binding at the primer site of HIV-1 RT was developed using the fluorescent probe, 2', 3'-trinitrophenyl-adenosine triphosphate. The Kd was found to be 21 uM. In fluorescence reversal assays, short oligodeoxynucleotides that act as primer analogs for RT showed increasing affinity with increasing length up to about 15 nucleotides. With polynucleotides, RT bound along the length of the nucleic acid and not just to the ends. Unfractionated tRNA and E coli tRNA(Trp) bound to RT with higher affinity than the synthetic oligodeoxynucleotides. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD91-18002).
Keywords: Capsid/*METABOLISM DNA/*METABOLISM HIV-1/*METABOLISM Retroviridae Proteins/*METABOLISM RNA/*METABOLISM RNA-Directed DNA Polymerase/METABOLISM Viral Core Proteins/*METABOLISM THESISKWDcapsid/KWDmetabolismdna/KWDmetabolismhiv-1/KWDmetabolismretroviridaeproteins/KWDmetabolismrna/KWDmetabolismrna-directeddnapolymerase/metabolismviralcoreproteins/KWDmetabolismthesis
920228
M9220881

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .